B2B SaaS Provider · B2C Consumer App / Platform · vs · B2C Consumer App / Platform
Doctolib vs SelectQuote
Structured technology and market comparison · 2026
Direct Feature Comparison
Doctolib · vs · SelectQuoteHealthcare booking and practice software platform for providers and patients.
Direct-to-consumer insurance distribution and senior healthcare platform.
Analyze all overlapping signals and tech stacks for Doctolib and SelectQuote
Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.
Comparison Analysis
What is the main difference between Doctolib and SelectQuote?
When comparing Doctolib and SelectQuote, both platforms operate within the B2C Consumer App / Platform ecosystem. Doctolib is positioned as Healthcare booking and practice software platform for providers and patients, whereas SelectQuote focuses on Direct-to-consumer insurance distribution and senior healthcare platform. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.
What are the top alternatives to Doctolib and SelectQuote?
When evaluating Doctolib and SelectQuote, enterprise buyers also consider other platforms in B2C Consumer App / Platform. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.
How do the corporate scale, structure, and headquarters of Doctolib and SelectQuote compare?
Doctolib is headquartered in FR (founded in 2013) with 1,001–5,000 employees. SelectQuote is based in US (founded in 1984) with 1,001–5,000 employees. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.
Market Signals
Recent Market Signals & Activity: Doctolib vs SelectQuote
Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.
Doctolib
Recent Signals
- ·Trending Topics (DACH/CEE Innovation & Tech)AI Investment
Nvidia invests in Doctolib, Pigment, Genesis AI, Entalpic
European tech startups raised €15.8 billion in September, nearly five times August's €3.2 billion, with the UK attracting the largest share (46%). Mega-deals included Mistral's €3 billion Series D and Nscale's $3.36 billion convertible notes; even excluding these, funding tripled month-over-month. Nvidia continued its European expansion by announcing minority investments in four French startups (Doctolib, Genesis AI, Pigment, Entalpic) and five UK startups (Boltz, Foresight, Hiverge, Prima Mente, Riverlane), as part of nearly €9 billion in European commitments. CEO Jensen Huang also announced a $250 million compute donation to UK AI safety and research. Critics question circular financing, while Huang advocates continued dialogue with Chinese AI firms. These moves follow Nvidia's recent agreement to acquire Hugging Face for about $12.9 billion.
- European startups raised €15.8 billion in September, nearly five times August's €3.2 billion.
- Nvidia announced minority investments in four French (Doctolib, Genesis AI, Pigment, Entalpic) and five UK (Boltz, Foresight, Hiverge, Prima Mente, Riverlane) startups, with total European commitment near €9 billion.
- Mistral raised €3 billion in Series D at a valuation over €21 billion, the largest equity round for a European tech company.
- ·Trending Topics (DACH/CEE Innovation & Tech)AI
Nvidia Invests in Four French Tech Companies
Nvidia has announced investments in four French technology companies during Jensen Huang's visit to Paris. The companies are Doctolib, a healthcare appointment platform; Genesis AI, a robotics startup; Pigment, a financial planning software maker; and Entalpic, a materials research startup. The deals are minority stakes, but the specific amounts and equity sizes were not disclosed. Nvidia's investment in Doctolib is intended to support its development of AI agents and a digital health companion. This move is part of Nvidia's broader commitment of nearly $10 billion to Europe's tech ecosystem, with plans to announce an additional $2 billion in European deals within a week. The investments have drawn criticism over potential circular financing, where AI firms use the funds to buy Nvidia chips, but Huang rejects these claims.
- Nvidia invests in Doctolib, Genesis AI, Pigment, and Entalpic.
- The investments are minority stakes; amounts undisclosed.
- Investment in Doctolib supports its AI agent and health companion work.
SelectQuote
Recent Signals
- ·SEC APIfinancials
10-K Financial Filing Analysis for SelectQuote (2026-08-25)
SelectQuote, Inc. reported its annual financial results and business overview in its Form 10-K for the fiscal year ended June 30, 2026. The company operates a technology-driven, direct-to-consumer distribution platform for insurance policies and healthcare services, leveraging proprietary AI/ML algorithms to optimize lead acquisition and customer lifetime value (LTV). During fiscal 2026, SelectQuote accelerated strategic investments in operational AI—including contact center conversational voice systems—while intentionally expanding its Healthcare Services division (anchored by SelectRx pharmacy operations and SelectPatient Management) and de-emphasizing its Auto & Home distribution business. Top carrier partners UnitedHealthcare, Humana, and Aetna represented a combined 64% of consolidated revenues. The company also disclosed active corporate initiatives including an NYSE minimum share price deficiency notice received in March 2026, for which it is seeking shareholder approval to implement a reverse stock split, and ongoing legal defense regarding a federal False Claims Act qui tam matter.
- SelectQuote's top three carrier partners (UnitedHealthcare at 39%, Humana at 13%, and Aetna at 12%) generated 64% of total consolidated revenue in fiscal year 2026.
- For the fiscal year ended June 30, 2026, the company sold over 635,000 Senior segment policies (89% Medicare Advantage) and generated more than $200 million in new premiums across its Life and Auto & Home segments.
- SelectRx grew its active patient base to over 109,000 members as of June 30, 2026, backed by fulfillment expansion at its Olathe, Kansas facility.
Compare their exact ecosystem overlaps.
Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners Doctolib and SelectQuote share across the market ecosystem.
Unlock full capability matrix, client overlaps & technology stacks